Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Longitudinal characterization of depression and mood states beginning in primary HIV infection.

Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S.

AIDS Behav. 2014 Jun;18(6):1124-32. doi: 10.1007/s10461-013-0688-5.

PMID:
24385231
2.

Factor structure of the Beck Depression Inventory-II among South Africans receiving antiretroviral therapy.

Kagee A, Nel A, Saal W.

AIDS Care. 2014 Feb;26(2):257-62. doi: 10.1080/09540121.2013.802278. Epub 2013 Jun 11.

PMID:
23750786
3.

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.

Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F.

HIV Med. 2006 Mar;7(2):112-21.

4.

A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.

Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR.

Arch Gen Psychiatry. 2010 Dec;67(12):1282-90. doi: 10.1001/archgenpsychiatry.2010.160.

5.

Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale.

Patterson K, Young C, Woods SP, Vigil O, Grant I, Atkinson JH; HIV Neurobehavioral Research Center Group.

Int J Methods Psychiatr Res. 2006 Jun;15(2):75-82. doi: 10.1002/mpr.184.

PMID:
19722288
6.

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R.

Arch Gen Psychiatry. 1996 Feb;53(2):175-82.

PMID:
8629893
7.

Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals.

Hinkin CH, van Gorp WG, Satz P, Weisman JD, Thommes J, Buckingham S.

J Clin Exp Neuropsychol. 1992 Mar;14(2):289-97.

PMID:
1572950
8.

Mood improvement reduces memory complaints in depressed patients.

Antikainen R, Hänninen T, Honkalampi K, Hintikka J, Koivumaa-Honkanen H, Tanskanen A, Viinamäki H.

Eur Arch Psychiatry Clin Neurosci. 2001;251(1):6-11.

PMID:
11315519
9.
10.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, Mcarthur JC; CHARTER Group.

J Neurovirol. 2016 Aug;22(4):479-87. doi: 10.1007/s13365-015-0416-1. Epub 2016 Jan 4.

PMID:
26727907
11.

Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.

Griffith NM, Szaflarski JP, Szaflarski M, Kent GP, Schefft BK, Howe SR, Privitera MD.

Epilepsy Behav. 2005 Sep;7(2):266-72.

PMID:
16005686
12.

Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease.

Perkins DO, Leserman J, Stern RA, Baum SF, Liao D, Golden RN, Evans DL.

Am J Psychiatry. 1995 Dec;152(12):1776-81.

PMID:
8526245
13.

Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: a longitudinal mediation analysis.

Magidson JF, Blashill AJ, Safren SA, Wagner GJ.

AIDS Behav. 2015 Jan;19(1):34-40. doi: 10.1007/s10461-014-0802-3.

14.

Factors associated with risk of depression and relevant predictors of screening for depression in clinical practice: a cross-sectional study among HIV-infected individuals in Denmark.

Slot M, Sodemann M, Gabel C, Holmskov J, Laursen T, Rodkjaer L.

HIV Med. 2015 Aug;16(7):393-402. doi: 10.1111/hiv.12223. Epub 2015 Jan 14.

PMID:
25585857
15.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
16.

Motivational symptoms of depression mask preclinical Alzheimer's disease in elderly subjects.

Bartolini M, Coccia M, Luzzi S, Provinciali L, Ceravolo MG.

Dement Geriatr Cogn Disord. 2005;19(1):31-6. Epub 2004 Sep 21.

PMID:
15383743
17.

Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Blashill AJ, Gordon JR, Safren SA.

J Behav Med. 2014 Feb;37(1):166-72. doi: 10.1007/s10865-012-9476-3. Epub 2012 Nov 22.

18.
19.

The Role of Depression in Retention in Care for Persons Living with HIV.

Zuniga JA, Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D.

AIDS Patient Care STDS. 2016 Jan;30(1):34-8. doi: 10.1089/apc.2015.0214. Epub 2015 Nov 6.

PMID:
26544915
20.

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):282-92. doi: 10.1097/QAI.0b013e31827ed678.

Items per page

Supplemental Content

Write to the Help Desk